Can Renal Mass Biopsy Improve Outcomes? Impact on Clinical Decision-Making

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

More frequent utilization of cross-sectional imaging has led to an increase in the incidental diagnosis and a subsequent rise in incidence of small renal masses. Historical biases and technical limitations have prevented renal mass biopsy (RMB) from becoming a universal part of routine patient evaluation at the time of diagnosis of a renal mass. Nevertheless, more recently, RMB is being more commonly utilized and offers real-world utility in risk-stratifying patients and appropriately matching them with an optimal treatment strategy.

Original languageEnglish (US)
Title of host publicationRenal Mass Biopsy
Subtitle of host publicationIndications, Risks, Technical Aspects and Future Trends
PublisherSpringer International Publishing
Pages13-30
Number of pages18
ISBN (Electronic)9783030360368
ISBN (Print)9783030360351
DOIs
StatePublished - Jan 1 2020
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • General Medicine

Fingerprint

Dive into the research topics of 'Can Renal Mass Biopsy Improve Outcomes? Impact on Clinical Decision-Making'. Together they form a unique fingerprint.

Cite this